Tapewire

Nasdaq · USD

RYTM

RHYTHM PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
3693
SEC CIK
0001649904
Parsed reports
430

Last 12 months

Inside the activity.

0 purchase rows · 50 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202501
Jan 202600
Feb 2026023
Mar 202601
Apr 202600
May 202601
Jun 202601
Jul 202600
Aug 2026015
Sep 202605
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 13, 2025 Filed Aug 14, 2025 22:48 UTC
Smith Hunter CChief Financial Officer
SaleCommon Stock 3,477 $96.00 $333,792.00
Disclosure

SEC source: 0001104659-25-078815 · tm2523328-3_4seq1.xml · nonDerivative · entry 4

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,915

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025.

Read SEC document
August 13, 2025 Filed Aug 14, 2025 22:48 UTC
Smith Hunter CChief Financial Officer
Exercise / conversionCommon Stock 3,477 $6.88 $23,921.76
Disclosure

SEC source: 0001104659-25-078815 · tm2523328-3_4seq1.xml · nonDerivative · entry 3

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,392

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 22:47 UTC
German Christopher PaulCorporate Controller & CAO
Exercise / conversionStock Options (Right to Buy) · Derivative 500 $0.00 Strike: $49.23 $0.00
Disclosure

SEC source: 0001104659-25-078814 · tm2523328-2_4seq1.xml · derivative · entry 5

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,050

Underlying: Common Stock · 500 shares

Expires 2034-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 22:47 UTC
German Christopher PaulCorporate Controller & CAO
Exercise / conversionStock Options (Right to Buy) · Derivative 1,000 $0.00 Strike: $17.97 $0.00
Disclosure

SEC source: 0001104659-25-078814 · tm2523328-2_4seq1.xml · derivative · entry 4

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,231

Underlying: Common Stock · 1,000 shares

Expires 2033-04-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock options were granted on April 4, 2023. The options vest and become exercisable as to 25% of the total shares on March 20, 2024 and, thereafter, as to the remaining 75% of the total shares in twelve equal quarterly installments of 6.25% beginning June 20, 2024 and ending March 20, 2027, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 22:47 UTC
German Christopher PaulCorporate Controller & CAO
SaleCommon Stock 1,500 $95.00 $142,500.00
Disclosure

SEC source: 0001104659-25-078814 · tm2523328-2_4seq1.xml · nonDerivative · entry 3

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 922

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2025.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 22:47 UTC
German Christopher PaulCorporate Controller & CAO
Exercise / conversionCommon Stock 500 $49.23 $24,615.00
Disclosure

SEC source: 0001104659-25-078814 · tm2523328-2_4seq1.xml · nonDerivative · entry 2

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,422

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 22:47 UTC
German Christopher PaulCorporate Controller & CAO
Exercise / conversionCommon Stock 1,000 $17.97 $17,970.00
Disclosure

SEC source: 0001104659-25-078814 · tm2523328-2_4seq1.xml · nonDerivative · entry 1

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,922

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 22:48 UTC
Smith Hunter CChief Financial Officer
Exercise / conversionStock Options (Right to Buy) · Derivative 24,611 $0.00 Strike: $6.88 $0.00
Disclosure

SEC source: 0001104659-25-078815 · tm2523328-3_4seq1.xml · derivative · entry 5

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,477

Underlying: Common Stock · 24,611 shares

Expires 2027-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option is fully vested.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 22:48 UTC
Smith Hunter CChief Financial Officer
SaleCommon Stock 24,611 $96.33 $2,370,831.77
Disclosure

SEC source: 0001104659-25-078815 · tm2523328-3_4seq1.xml · nonDerivative · entry 2

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,915

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $96.00 to $96.63 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 22:48 UTC
Smith Hunter CChief Financial Officer
Exercise / conversionCommon Stock 24,611 $6.88 $169,323.68
Disclosure

SEC source: 0001104659-25-078815 · tm2523328-3_4seq1.xml · nonDerivative · entry 1

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 141,526

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 22:32 UTC
Shulman JosephChief Technical Officer
Exercise / conversionStock Options (Right to Buy) · Derivative 3,984 $0.00 Strike: $6.80 $0.00
Disclosure

SEC source: 0001104659-25-077706 · tm2523328-1_4seq1.xml · derivative · entry 3

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,969

Underlying: Common Stock · 3,984 shares

Expires 2032-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 22:32 UTC
Shulman JosephChief Technical Officer
SaleCommon Stock 3,984 $90.08 $358,891.47
Disclosure

SEC source: 0001104659-25-077706 · tm2523328-1_4seq1.xml · nonDerivative · entry 2

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,509

F1 · kind: The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted on August 8, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $90.00 to $90.27 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 22:32 UTC
Shulman JosephChief Technical Officer
Exercise / conversionCommon Stock 3,984 $6.80 $27,091.20
Disclosure

SEC source: 0001104659-25-077706 · tm2523328-1_4seq1.xml · nonDerivative · entry 1

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,493

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 29, 2025 Filed Jul 29, 2025 22:56 UTC
Cramer Pamela J.Chief Human Resources Officer
SaleCommon Stock 1,520 $85.93 $130,613.60
Disclosure

SEC source: 0001104659-25-071849 · tm2522015-1_4seq1.xml · nonDerivative · entry 2

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,814

F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
July 26, 2025 Filed Jul 29, 2025 22:56 UTC
Cramer Pamela J.Chief Human Resources Officer
Exercise / conversionRestricted Stock Units · Derivative 3,125 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-071849 · tm2522015-1_4seq1.xml · derivative · entry 3

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,125 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of July 26, 2022, July 26, 2023, July 26, 2024 and July 26, 2025. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of July 26, 2022, July 26, 2023, July 26, 2024 and July 26, 2025. The restricted stock units have no expiration date.

Read SEC document
July 26, 2025 Filed Jul 29, 2025 22:56 UTC
Cramer Pamela J.Chief Human Resources Officer
Exercise / conversionCommon Stock 3,125 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-25-071849 · tm2522015-1_4seq1.xml · nonDerivative · entry 1

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,334

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:30 UTC
Cramer Pamela J.Chief Human Resources Officer
Exercise / conversionStock Options (Right to Buy) · Derivative 5,025 $0.00 Strike: $27.35 $0.00
Disclosure

SEC source: 0001104659-25-067427 · tm2520691-1_4seq1.xml · derivative · entry 7

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,075

Underlying: Common Stock · 5,025 shares

Expires 2033-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock options were granted on February 1, 2023. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:30 UTC
Cramer Pamela J.Chief Human Resources Officer
Exercise / conversionStock Options (Right to Buy) · Derivative 10,547 $0.00 Strike: $6.80 $0.00
Disclosure

SEC source: 0001104659-25-067427 · tm2520691-1_4seq1.xml · derivative · entry 6

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,581

Underlying: Common Stock · 10,547 shares

Expires 2032-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:30 UTC
Cramer Pamela J.Chief Human Resources Officer
SaleCommon Stock 3,516 $80.00 $281,280.00
Disclosure

SEC source: 0001104659-25-067427 · tm2520691-1_4seq1.xml · nonDerivative · entry 5

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,209

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:30 UTC
Cramer Pamela J.Chief Human Resources Officer
SaleCommon Stock 7,831 $76.69 $600,564.87
Disclosure

SEC source: 0001104659-25-067427 · tm2520691-1_4seq1.xml · nonDerivative · entry 4

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,725

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $76.17 to $76.75 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:30 UTC
Cramer Pamela J.Chief Human Resources Officer
SaleCommon Stock 4,225 $75.55 $319,217.34
Disclosure

SEC source: 0001104659-25-067427 · tm2520691-1_4seq1.xml · nonDerivative · entry 3

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,556

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $75.08 to $75.98 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:30 UTC
Cramer Pamela J.Chief Human Resources Officer
Exercise / conversionCommon Stock 5,025 $27.35 $137,433.75
Disclosure

SEC source: 0001104659-25-067427 · tm2520691-1_4seq1.xml · nonDerivative · entry 2

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,781

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:30 UTC
Cramer Pamela J.Chief Human Resources Officer
Exercise / conversionCommon Stock 10,547 $6.80 $71,719.60
Disclosure

SEC source: 0001104659-25-067427 · tm2520691-1_4seq1.xml · nonDerivative · entry 1

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 29,756

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:30 UTC
German Christopher PaulCorporate Controller & CAO
Exercise / conversionStock Options (Right to Buy) · Derivative 850 $0.00 Strike: $49.23 $0.00
Disclosure

SEC source: 0001104659-25-067428 · tm2520691-2_4seq1.xml · derivative · entry 6

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,550

Underlying: Common Stock · 850 shares

Expires 2034-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:30 UTC
German Christopher PaulCorporate Controller & CAO
Exercise / conversionStock Options (Right to Buy) · Derivative 2,000 $0.00 Strike: $17.97 $0.00
Disclosure

SEC source: 0001104659-25-067428 · tm2520691-2_4seq1.xml · derivative · entry 5

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,231

Underlying: Common Stock · 2,000 shares

Expires 2033-04-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock options were granted on April 4, 2023. The options vest and become exercisable as to 25% of the total shares on March 20, 2024 and, thereafter, as to the remaining 75% of the total shares in twelve equal quarterly installments of 6.25% beginning June 20, 2024 and ending March 20, 2027, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:30 UTC
German Christopher PaulCorporate Controller & CAO
SaleCommon Stock 1,850 $85.00 $157,250.00
Disclosure

SEC source: 0001104659-25-067428 · tm2520691-2_4seq1.xml · nonDerivative · entry 4

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 922

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2025.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:30 UTC
German Christopher PaulCorporate Controller & CAO
SaleCommon Stock 1,967 $76.75 $150,967.25
Disclosure

SEC source: 0001104659-25-067428 · tm2520691-2_4seq1.xml · nonDerivative · entry 3

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,772

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2025.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:30 UTC
German Christopher PaulCorporate Controller & CAO
Exercise / conversionCommon Stock 850 $49.23 $41,845.50
Disclosure

SEC source: 0001104659-25-067428 · tm2520691-2_4seq1.xml · nonDerivative · entry 2

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,739

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:30 UTC
German Christopher PaulCorporate Controller & CAO
Exercise / conversionCommon Stock 2,000 $17.97 $35,940.00
Disclosure

SEC source: 0001104659-25-067428 · tm2520691-2_4seq1.xml · nonDerivative · entry 1

German Christopher Paul · CIK 0001260835 · Corporate Controller & CAO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,889

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:31 UTC
Smith Hunter CChief Financial Officer
Exercise / conversionStock Options (Right to Buy) · Derivative 42,120 $0.00 Strike: $6.88 $0.00
Disclosure

SEC source: 0001104659-25-067431 · tm2520691-4_4seq1.xml · derivative · entry 5

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,088

Underlying: Common Stock · 42,120 shares

Expires 2027-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option is fully vested.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:31 UTC
Smith Hunter CChief Financial Officer
SaleCommon Stock 23,400 $84.50 $1,977,300.00
Disclosure

SEC source: 0001104659-25-067431 · tm2520691-4_4seq1.xml · nonDerivative · entry 4

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,915

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:31 UTC
Smith Hunter CChief Financial Officer
SaleCommon Stock 1,607 $76.17 $122,406.31
Disclosure

SEC source: 0001104659-25-067431 · tm2520691-4_4seq1.xml · nonDerivative · entry 3

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 140,315

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $76.17 to $76.18 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:31 UTC
Smith Hunter CChief Financial Officer
SaleCommon Stock 17,113 $75.38 $1,290,049.81
Disclosure

SEC source: 0001104659-25-067431 · tm2520691-4_4seq1.xml · nonDerivative · entry 2

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 141,922

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $75.01 to $75.70 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:31 UTC
Smith Hunter CChief Financial Officer
Exercise / conversionCommon Stock 42,120 $6.88 $289,785.60
Disclosure

SEC source: 0001104659-25-067431 · tm2520691-4_4seq1.xml · nonDerivative · entry 1

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 159,035

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:30 UTC
Shulman JosephChief Technical Officer
Exercise / conversionStock Options (Right to Buy) · Derivative 7,969 $0.00 Strike: $6.80 $0.00
Disclosure

SEC source: 0001104659-25-067430 · tm2520691-3_4seq1.xml · derivative · entry 4

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,953

Underlying: Common Stock · 7,969 shares

Expires 2032-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:30 UTC
Shulman JosephChief Technical Officer
SaleCommon Stock 3,985 $80.00 $318,800.00
Disclosure

SEC source: 0001104659-25-067430 · tm2520691-3_4seq1.xml · nonDerivative · entry 3

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,509

F1 · kind: The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted on August 8, 2024.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:30 UTC
Shulman JosephChief Technical Officer
SaleCommon Stock 3,984 $75.56 $301,050.56
Disclosure

SEC source: 0001104659-25-067430 · tm2520691-3_4seq1.xml · nonDerivative · entry 2

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,494

F1 · kind: The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted on August 8, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $75.12 to $75.92 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 09, 2025 Filed Jul 11, 2025 20:30 UTC
Shulman JosephChief Technical Officer
Exercise / conversionCommon Stock 7,969 $6.80 $54,189.20
Disclosure

SEC source: 0001104659-25-067430 · tm2520691-3_4seq1.xml · nonDerivative · entry 1

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,478

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 07, 2025 Filed Jul 8, 2025 20:30 UTC
Smith Hunter CChief Financial Officer
Exercise / conversionStock Options (Right to Buy) · Derivative 6,986 $0.00 Strike: $6.88 $0.00
Disclosure

SEC source: 0001104659-25-066420 · tm2520047-1_4seq1.xml · derivative · entry 2

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,208

Underlying: Common Stock · 6,986 shares

Expires 2027-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock option is fully vested.

Read SEC document
July 07, 2025 Filed Jul 8, 2025 20:30 UTC
Smith Hunter CChief Financial Officer
Exercise / conversionCommon Stock 6,986 $6.88 $48,063.68
Disclosure

SEC source: 0001104659-25-066420 · tm2520047-1_4seq1.xml · nonDerivative · entry 1

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,915

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 02, 2025 Filed Jul 3, 2025 21:12 UTC
Garfield AlastairChief Scientific Officer
SaleCommon Stock 6 $64.60 $387.60
Disclosure

SEC source: 0001104659-25-065844 · tm2519881-1_4seq1.xml · nonDerivative · entry 3

Garfield Alastair · CIK 0002027261 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,126

F2 · kind: The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted on June 25, 2024 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
July 02, 2025 Filed Jul 3, 2025 21:12 UTC
Garfield AlastairChief Scientific Officer
SaleCommon Stock 1,313 $64.81 $85,095.53
Disclosure

SEC source: 0001104659-25-065844 · tm2519881-1_4seq1.xml · nonDerivative · entry 2

Garfield Alastair · CIK 0002027261 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,132

F2 · kind: The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted on June 25, 2024 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
July 01, 2025 Filed Jul 3, 2025 21:12 UTC
Garfield AlastairChief Scientific Officer
Exercise / conversionRestricted Stock Units · Derivative 4,445 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-065844 · tm2519881-1_4seq1.xml · derivative · entry 4

Garfield Alastair · CIK 0002027261 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,333

Underlying: Common Stock · 4,445 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total restricted stock units on each of the first four anniversaries of July 1, 2024, subject to the Reporting Person's continued service on each such vesting date. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total restricted stock units on each of the first four anniversaries of July 1, 2024, subject to the Reporting Person's continued service on each such vesting date. The restricted stock units have no expiration date.

Read SEC document
July 01, 2025 Filed Jul 3, 2025 21:12 UTC
Garfield AlastairChief Scientific Officer
Exercise / conversionCommon Stock 4,445 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-25-065844 · tm2519881-1_4seq1.xml · nonDerivative · entry 1

Garfield Alastair · CIK 0002027261 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,445

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Read SEC document
June 24, 2025 Filed Jun 26, 2025 20:45 UTC GrantRestricted Stock Units · Derivative 4,712 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-063076 · tm2519230-6_4seq1.xml · derivative · entry 2

GOOD JENNIFER L · CIK 0001229245 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,712

Underlying: Common Stock · 4,712 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.

Read SEC document
June 24, 2025 Filed Jun 26, 2025 20:45 UTC GrantStock Option (right to buy) · Derivative 7,037 $0.00 Strike: $63.66 $0.00
Disclosure

SEC source: 0001104659-25-063076 · tm2519230-6_4seq1.xml · derivative · entry 1

GOOD JENNIFER L · CIK 0001229245 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,037

Underlying: Common Stock · 7,037 shares

Expires 2035-06-23

F1 · derivative.exercise_date: The options fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
June 24, 2025 Filed Jun 26, 2025 20:30 UTC GrantRestricted Stock Units · Derivative 4,712 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-063064 · tm2519230-1_4seq1.xml · derivative · entry 2

MCGIRR DAVID W J · CIK 0001219023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,712

Underlying: Common Stock · 4,712 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.

Read SEC document
June 24, 2025 Filed Jun 26, 2025 20:30 UTC GrantStock Option (right to buy) · Derivative 7,037 $0.00 Strike: $63.66 $0.00
Disclosure

SEC source: 0001104659-25-063064 · tm2519230-1_4seq1.xml · derivative · entry 1

MCGIRR DAVID W J · CIK 0001219023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,037

Underlying: Common Stock · 7,037 shares

Expires 2035-06-23

F1 · derivative.exercise_date: The options fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date.

Read SEC document
June 24, 2025 Filed Jun 26, 2025 20:56 UTC GrantRestricted Stock Units · Derivative 4,712 $0.00 $0.00
Disclosure

SEC source: 0001104659-25-063080 · tm2519230-3_4seq1.xml · derivative · entry 2

Bedrosian Camille L · CIK 0001326969 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,712

Underlying: Common Stock · 4,712 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.

Read SEC document
June 24, 2025 Filed Jun 26, 2025 20:56 UTC GrantStock Option (right to buy) · Derivative 7,037 $0.00 Strike: $63.66 $0.00
Disclosure

SEC source: 0001104659-25-063080 · tm2519230-3_4seq1.xml · derivative · entry 1

Bedrosian Camille L · CIK 0001326969 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,037

Underlying: Common Stock · 7,037 shares

Expires 2035-06-23

F1 · derivative.exercise_date: The options fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.